S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
Log in
NASDAQ:ALBO

Albireo Pharma SEC Filings & 10K Form

$33.87
-0.60 (-1.74 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$32.81
Now: $33.87
$34.95
50-Day Range
$34.47
MA: $37.59
$42.85
52-Week Range
$11.26
Now: $33.87
$49.00
Volume244,464 shs
Average Volume185,502 shs
Market Capitalization$647.39 million
P/E RatioN/A
Dividend YieldN/A
Beta1.62

SEC Filings

Albireo Pharma (NASDAQ:ALBO) SEC Filings

DateFilerForm TypeView
03/05/2021
5:08 AM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4/A
03/03/2021
5:45 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:51 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
7:45 AM
Albireo Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
7:05 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
2:36 PM
Albireo Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/16/2021
12:29 PM
Albireo Pharma (Subject)
ArrowMark Colorado Holdings LLC (Filed by)
Form SC 13G/A
02/12/2021
12:16 PM
Albireo Pharma (Subject)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
02/12/2021
6:01 AM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
02/11/2021
12:30 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
4:46 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:44 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:42 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:41 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:39 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:37 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:34 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:33 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
4:26 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4/A
01/25/2021
7:11 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2021
3:15 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
3:19 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2020
3:35 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
7:18 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2020
7:15 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:40 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2020
4:05 PM
Albireo Pharma (Subject)
TVM Life Science Ventures VI LP (Filed by)
Form SC 13D/A
10/23/2020
3:21 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
3:19 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2020
3:33 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/13/2020
3:06 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
4:05 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
3:18 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:30 AM
Albireo Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
8:02 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:54 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
7:49 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
3:25 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2020
3:22 PM
Albireo Pharma (Filer)
Form 424B5
09/09/2020
3:22 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
3:57 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2020
3:35 PM
Albireo Pharma (Filer)
Form 424B5
09/08/2020
5:40 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
08/18/2020
3:56 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2020
6:39 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2020
3:15 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2020
4:50 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
4:02 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:59 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:53 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:24 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:20 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:09 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:06 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:19 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
6:37 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
05/07/2020
7:06 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
6:37 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
7:57 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
10:12 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
9:33 AM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
02/04/2020
7:00 AM
Albireo Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
4:16 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2020
3:03 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2020
3:02 PM
Albireo Pharma (Filer)
Form 424B5
01/29/2020
3:44 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
3:43 PM
Albireo Pharma (Filer)
Form 424B5
01/23/2020
7:10 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
7:09 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:49 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:45 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:42 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:32 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:28 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:22 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:18 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
8:06 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:38 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
3:51 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:46 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2019
8:17 AM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
7:29 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:07 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
4:21 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:00 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:56 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:53 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:49 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:47 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:01 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
12:37 PM
Albireo Pharma (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
05/09/2019
9:09 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:47 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
3:02 PM
Albireo Pharma (Filer)
Form 424B3
04/30/2019
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
04/25/2019
3:05 PM
Albireo Pharma (Filer)
Form DEFA14A
04/25/2019
3:03 PM
Albireo Pharma (Filer)
Form DEF 14A
04/03/2019
5:02 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.